Top Markets
#1 Islamic Coin Islamic Coin +152.22%
#2 Bitway Bitway +67.08%
#3 Starpower Starpower +34.74%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +28.76%
#5 aelf aelf +26.48%
#6 Pons Pons +16.47%
#7 Decred Decred +14.39%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +14.08%
#9 Ribbita by Virtuals Ribbita by Virtuals +13.52%
#10 DAPPOS DAPPOS +10.73%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Acasti Pharma Inc. Acasti Pharma Inc.

Acasti Pharma Inc.

ACST
Rank in Stocks #29930
Acasti Pharma Inc. is a biopharmaceutical company dedicated to the research,... Acasti Pharma Inc. is a biopharmaceutical company dedicated to the research, development, and market introduction of pharmaceutical solutions for cardiovascular conditions. The firm is currently exploring strategic collaborations to further the clinical advancement of its compound, CaPre. Established in 2002, Acasti Pharma Inc. maintains its principal operations from its headquarters in Laval, Canada.
Share Price
$0.4256834
Last synced: 2023-03-27
Market Cap
$18.99M
Change (1 day)
3.08%
Change (1 year)
0.00%
Country
CA
Trade Acasti Pharma Inc. (ACST)

Category

Healthcare
Revenue for Acasti Pharma Inc. (ACST)
Revenue in Aug 2026 TTM: 0
According to Acasti Pharma Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Acasti Pharma Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR